Combined model-based and patient-specific dosimetry for 18 F-DCFPyL, a PSMA-targeted PET agent
Conclusions18F-DCFPyL dosimetry in nine patients was obtained using novel models for the lacrimal and salivary glands, two organs with potentially dose-limiting uptake for therapy and diagnosis which lacked pre-existing models.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Anatomy | Bladder Cancer | Cancer | Cancer & Oncology | CT Scan | Nuclear Medicine | PET Scan | Prostate Cancer | Urology & Nephrology